Author:
Martin Carmen Sorina,Ionescu Luminita Nicoleta,Barbu Carmen Gabriela,Sirbu Anca Elena,Lambrescu Ioana Maria,Lacau Ioana Smarandita,Dimulescu Doina Ruxandra,Fica Simona Vasilica
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. World health organization, “hepatitis C. Fact sheet number 164,” 2012. [http://www.who.int/mediacentre/factsheets/fs164/en]
2. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347 (13): 975-982. 10.1056/NEJMoa020047.
3. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G: Long-term outcome of interferon-Alfa induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab. 2001, 86 (5): 1925-1929.
4. Tomer Y, Peters JJ, Menconi F: Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab. 2009, 23 (6): 703-712. 10.1016/j.beem.2009.07.004.
5. Koh LK, Greenspan FS, Yeo PP: Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. Thyroid. 1997, 7: 891-896. 10.1089/thy.1997.7.891.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献